Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04081779 · ClinicalTrials.gov registry record · NA
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
A NA study of Lymphoma and Breast Carcinoma, sponsored by Fred Hutchinson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 261
- Enrollment target
- 1
- Study location
NCT04081779: Active NA study of Lymphoma and Breast Carcinoma, sponsored by Fred Hutchinson Cancer Center.
NCT04081779 is a NA study of Lymphoma and Breast Carcinoma that is active but no longer recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 261 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04081779, a NA study of Lymphoma and Breast Carcinoma, is active but no longer recruiting, sponsored by Fred Hutchinson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 261 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Supportive Care
- OTHER Educational Intervention
- OTHER Survivorship Care Plan
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04081779 still lists
NCT04081779 is an interventional study that assigns participants to a tested intervention. The registered 261 participants enrollment target is mid-sized for trials with a published cap, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (46% lower).
The record links to 5 conditions, with Lymphoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT04081779 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04081779 about?
NCT04081779 is a clinical study titled "Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study". This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care pl...
What is the current status of trial NCT04081779?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 261 participants. The study started on 2020-02-19. Estimated completion is 2026-03-31.
What conditions does trial NCT04081779 study?
This clinical trial studies the following conditions: Lymphoma, Breast Carcinoma, Prostate Carcinoma, Colorectal Carcinoma, Lung Carcinoma.
What interventions are being tested in trial NCT04081779?
The interventions under investigation include: Questionnaire Administration (OTHER), Supportive Care (OTHER), Educational Intervention (OTHER), Survivorship Care Plan (OTHER).
Who is sponsoring clinical trial NCT04081779?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04081779 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04081779's enrollment target sits among peer trials
261 40th of 299 higher than 260 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05124912 · 261 participants · NA
REMASTer: REcurrent Brain Metastases After SRS Trial
- NCT06559891 · 261 participants · NA
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI